[HLBANK] QoQ TTM Result on 31-Dec-2020 [#2]

Announcement Date
26-Feb-2021
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2021
Quarter
31-Dec-2020 [#2]
Profit Trend
QoQ- -1.22%
YoY- -5.89%
View:
Show?
TTM Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 5,497,964 5,466,873 5,331,236 5,074,659 4,912,115 4,778,356 4,749,526 10.23%
PBT 3,622,802 3,470,939 3,295,010 2,991,415 3,033,093 2,989,397 3,073,744 11.56%
Tax -632,812 -610,297 -554,437 -487,518 -498,170 -494,800 -512,114 15.13%
NP 2,989,990 2,860,642 2,740,573 2,503,897 2,534,923 2,494,597 2,561,630 10.84%
-
NP to SH 2,989,990 2,860,642 2,740,573 2,503,897 2,534,923 2,494,597 2,561,630 10.84%
-
Tax Rate 17.47% 17.58% 16.83% 16.30% 16.42% 16.55% 16.66% -
Total Cost 2,507,974 2,606,231 2,590,663 2,570,762 2,377,192 2,283,759 2,187,896 9.52%
-
Net Worth 29,448,800 29,461,726 28,539,430 28,251,912 28,067,153 27,221,136 26,360,066 7.65%
Dividend
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Div 1,023,667 1,023,667 711,922 711,922 736,781 736,781 1,023,078 0.03%
Div Payout % 34.24% 35.78% 25.98% 28.43% 29.07% 29.54% 39.94% -
Equity
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Net Worth 29,448,800 29,461,726 28,539,430 28,251,912 28,067,153 27,221,136 26,360,066 7.65%
NOSH 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 2,167,718 0.00%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 54.38% 52.33% 51.41% 49.34% 51.61% 52.21% 53.93% -
ROE 10.15% 9.71% 9.60% 8.86% 9.03% 9.16% 9.72% -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 268.28 267.02 260.40 247.88 239.94 233.47 232.07 10.13%
EPS 145.90 139.72 133.86 122.31 123.82 121.88 125.17 10.74%
DPS 50.00 50.00 34.78 34.78 36.00 36.00 50.00 0.00%
NAPS 14.37 14.39 13.94 13.80 13.71 13.30 12.88 7.56%
Adjusted Per Share Value based on latest NOSH - 2,167,718
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
RPS 268.20 266.68 260.07 247.55 239.62 233.10 231.69 10.23%
EPS 145.86 139.55 133.69 122.14 123.66 121.69 124.96 10.85%
DPS 49.94 49.94 34.73 34.73 35.94 35.94 49.91 0.04%
NAPS 14.3657 14.372 13.9221 13.7818 13.6917 13.279 12.8589 7.65%
Price Multiplier on Financial Quarter End Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 -
Price 18.90 18.72 18.70 18.20 15.04 14.08 13.46 -
P/RPS 7.04 7.01 7.18 7.34 6.27 6.03 5.80 13.77%
P/EPS 12.95 13.40 13.97 14.88 12.15 11.55 10.75 13.20%
EY 7.72 7.46 7.16 6.72 8.23 8.66 9.30 -11.66%
DY 2.65 2.67 1.86 1.91 2.39 2.56 3.71 -20.07%
P/NAPS 1.32 1.30 1.34 1.32 1.10 1.06 1.05 16.46%
Price Multiplier on Announcement Date
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Date 29/11/21 30/08/21 27/05/21 26/02/21 27/11/20 28/08/20 29/05/20 -
Price 18.20 19.18 18.26 18.00 17.02 14.00 13.60 -
P/RPS 6.78 7.18 7.01 7.26 7.09 6.00 5.86 10.20%
P/EPS 12.47 13.73 13.64 14.72 13.75 11.49 10.87 9.57%
EY 8.02 7.28 7.33 6.79 7.28 8.71 9.20 -8.73%
DY 2.75 2.61 1.90 1.93 2.12 2.57 3.68 -17.63%
P/NAPS 1.27 1.33 1.31 1.30 1.24 1.05 1.06 12.79%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment